Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1834-1842

  Gormsen, Lars C ^a,b   Jessen, N ^a   Gjedsted, J ^a   Gjedde, S ^a   Norrelund H ^a   Lund, S ^a   Christiansen, J S ^a   Nielsen, S ^a   Schmitz, O ^b   Moller N ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; FATTY ACID; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; LIPID; SOMATOSTATIN; CYTOKINE; HUMAN GROWTH HORMONE; HYPERGLYCEMIC AGENT; PALMITIC ACID DERIVATIVE;

ADULT; ARM MUSCLE; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; LIPID METABOLISM; LIPID OXIDATION; LIPOLYSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; BLOOD; BLOOD FLOW; CALORIMETRY; DRUG ANTAGONISM; DRUG EFFECT; FOREARM; GLUCOSE CLAMP TECHNIQUE; METABOLISM; MICRODIALYSIS; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VASCULARIZATION;

ADULT; CALORIMETRY, INDIRECT; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, NONESTERIFIED; FOREARM; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN ANTAGONISTS; LIPID METABOLISM; LIPOLYSIS; MALE; MICRODIALYSIS; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PALMITATES; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; SOMATOSTATIN;

EID: 34249850289     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2659     Document Type: Article

References (35)

1. Kanaley JA, Dall R, Moller N, Nielsen SC, Christiansen JS, Jensen MD, Jorgensen JOL 2004 Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men. J Appl Physiol 96:747-753
2. Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N 2001 The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50:96-104
3. Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J 1992 Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74:1012-1019
4. D'Amico S, Shi J, Sekhar RV, Jahoor F, Ellis KJ, Rehman K, Willis J, Maldonado M, Balasubramanyam A 2006 Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome. Am J Clin Nutr 84:204-211
5. Norrelund H, Nair KS, Nielsen S, Frystyk J, Ivarsen P, Jorgensen JO, Christiansen JS, Moller N 2003 The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 88:4371-4378
6. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865
7. Nielsen S, Moller N, Christiansen JS, Jorgensen JO 2001 Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50:2301-2308
8. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, DeFronzo RA, Cusi K 2005 Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54:1640-1648
9. Randle PJ, Garland PB, Hales CN, Newsholme EA 1963 The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
10. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C, Moser E, Waldhausl W 1999 Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48:358-364
11. Itani SI, Ruderman NB, Schmieder F, Boden G 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκBα. Diabetes 51:2005-2011
12. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK 2005 Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation 54. Diabetes 54:2939-2945
13. Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G, Olefsky JM 2002 Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87:226-234
14. Maccario M, Procopio M, Loche S, Cappa M, Martina V, Camanni F, Ghigo E 1994 Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism 43:223-226
15. Gormsen LC, Gjedsted J, Gjedde S, Vestergaard ET, Christiansen JS, Jorgensen JO, Nielsen S, Moller N 2006 Free fatty acids decrease circulating ghrelin concentrations in humans. Eur J Endocrinol 154:667-673
16. Steele R 1959 Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430
17. Ferrannini E 1988 The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301
18. Wojtaszewski JF, Hansen BF, Urso B, Richter EA 1996 Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J Appl Physiol 81:1501-1509
19. Harrison J, Hodson AW, Skillen AW, Stappenbeck R, Agius L, Alberti KG 1988 Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorometric attachment. J Clin Chem Clin Biochem 26:141-146
20. Berk PD, Bradbury M, Zhou SL, Stump D, Han NI 1996 Characterization of membrane transport processes: lessons from the study of BSP, bilirubin, and fatty acid uptake. Semin Liver Dis 16:107-120
21. Storgaard H, Jensen CB, Bjornholm M, Song XM, Madsbad S, Zierath JR, Vaag AA 2004 Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab 89:1301-1311
22. Christie AW, McCormick DK, Emmison N, Kraemer FB, Alberti KG, Yeaman SJ 1996 Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes. Diabetologia 39:45-53
23. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R 2004 Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383-1386
24. Zimmermann R, Haemmerle G, Wagner EM, Strauss JG, Kratky D, Zechner R 2003 Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue. J Lipid Res 44:2089-2099
25. Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E, Sattler W, Magin TM, Wagner EF, Zechner R 2002 Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J Biol Chem 277:4806-4815
26. Langin D, Dicker A, Tavernier G, Hoffstedt J, Mairal A, Ryden M, Arner E, Sicard A, Jenkins CM, Viguerie N, van Harmelen V, Gross RW, Holm C, Arner P 2005 Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54:3190-3197
27. Kershaw EE, Hamm JK, Verhagen LAW, Peroni O, Katic M, Flier JS 2006 Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 55:148-157
28. Mulder H, Sorhede-Winzell M, Contreras JA, Fex M, Strom K, Ploug T, Galbo H, Arner P, Lundberg C, Sundler F, Ahren B, Holm C 2003 Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. J Biol Chem 278:36380-36388
29. Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, Cline G, Li H, Prentki M, Shulman GI, Mitchell GA, Kim JK 2005 Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. Am J Physiol Endocrinol Metab 289:E30-E39
30. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259
31. Fulcher GR, Walker M, Farrer M, Johnson AS, Alberti KG 1993 Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism 42:308-314
32. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446
33. Wojtaszewski JF, Hansen BF, Kiens B, Richter EA 1997 Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes 46:1775-1781
34. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
35. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G 2003 Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 52:1799-1805